# Bryophyllum vs. Nifedipine

> **NCT00391339** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Weleda AG** · enrollment: 140 (—)

## Conditions studied

- Tocolysis

## Interventions

- **DRUG:** Bryophyllum p.

## Key facts

- **NCT ID:** NCT00391339
- **Lead sponsor:** Weleda AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2008-10
- **Target enrollment:** 140 (—)
- **Last updated:** 2006-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00391339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00391339, "Bryophyllum vs. Nifedipine". Retrieved via MORVS 2026-09-30 from https://api.morvs.ai/clinical/NCT00391339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*